Long-term effectiveness and safety of treatment with dupilumab in patients with atopic dermatitis: Results of the TREAT NL (TREatment of ATopic eczema, the Netherlands) registryAngela L. Bosma, Phyllis I. Spuls, Linde E. M. de Wijs et al.|Journal of the American Academy of Dermatology|2020Cited by 58
The International TREatment of ATopic Eczema (TREAT) Registry Taskforce: An Initiative to Harmonize Data Collection across National Atopic Eczema Photo- and Systemic Therapy RegistriesPhyllis I. Spuls, Carsten Flohr, Maritza A. Middelkamp‐Hup et al.|Journal of Investigative Dermatology|2017Cited by 32
TREatment of ATopic eczema (TREAT) Registry Taskforce: protocol for an international Delphi exercise to identify a core set of domains and domain items for national atopic eczema registriesLouise A. A. Gerbens, Carsten Flohr, Aaron Boyce et al.|Trials|2017Cited by 28
Mapping exercise and status update of eight established registries within the TREatment of ATopic eczema Registry TaskforceAngela L. Bosma, Phyllis I. Spuls, Annelie H. Musters et al.|Journal of the European Academy of Dermatology and Venereology|2022Cited by 21
Work ability and quality of working life in atopic dermatitis patients treated with dupilumabAngela L. Bosma, Phyllis I. Spuls, Wouter Ouwerkerk et al.|The Journal of Dermatology|2021Cited by 13